Zydus Gets Clean Chit From US FDA For Ambernath API Plant

Zydus Lifesciences Ltd. on Wednesday said it has received an Establishment Inspection Report from the US Food and Drug Administration for its active pharmaceutical ingredient manufacturing facility at Ambernath, Maharashtra.

The inspection, which took place from February 10–14, concluded with no observations, and the facility has been classified as ‘no action indicated’, the company said in an exchange filing.